The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Wrymark sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Wrymark is a medical equipment company that designs and manufactures orthotics and prosthetic devices. The company offers children’s orthotics, diabetic orthotics, active and athletic orthotics, heel cups, and foot plates. The company’s products assist orthopedic surgeons, podiatrists, physical therapists, and athletic trainers at the collegiate, olympic, and professional levels. Wrymark provides products under the brands 1st step orthotics, Resource labs, Dynaflex, and Foot tech. Wrymark is headquartered in St. Louis, Missouri, the US.
The key metrics of Wrymark related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Wrymark is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Wrymark.
For a detailed understanding of the performance of Wrymark, buy the report here.